Panos Stafylas is the Scientific Director of HealThink with more than 20 years' experience in Medicine, HTA and Pharmacoeconomics. He is an HTA consultant and Medical Doctor specialised in Cardiology with MBA in Healthcare Management and PhD in novel cardiovascular risk factors. He has worked as a clinical cardiologist, pharmacoeconomic consultant, scientific/medical coordinator and evaluation leader of European projects, tutor of HTA, pharmacoeconomics and clinical pharmacology. His first original pharmacoeconomic model was published in 2005 in the American Journal of Hypertension, and his first contract for pharmacoeconomic services with a pharmaceutical company was in 2008.
From 2010 till 2016, he has worked as the Scientific Coordinator of 3 European research projects, coordinating successfully multinational and multidisciplinary teams of experts. He has also worked as Evaluation (HTA) Leader and as Task Leader for data analysis in two more European projects for integrated care. He is a member of the Board of Directors of the MAST HTA framework supported by the European Commission and applied in most European Digital Health projects. He has performed HTA in more than 20 European countries. He has been invited by the European Commission, the European Parliament, and the OECD as an expert in HTA of complex interventions and integrated care.
He co-founded HealThink in 2014 to offer HTA and Research and Development (R & D) services to pharmaceutical companies, academic and research organisations, international consortia, and other SMEs. He is also affiliated academic staff in three Greek Universities (Aristotle University of Thessaloniki, National and Kapodistrian University of Athens, University of Macedonia), teaching HTA, pharmacoeconomics and clinical pharmacology. He is frequently invited to Greek and international congresses to present his experience or moderate relevant round tables.